🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆
Updated 21 Aug 2026 · ClinicalTrials.gov

Clinical Trials in New Jersey

← All US trials

The most recently updated industry-sponsored clinical trials recruiting across the United States — searchable by condition, sponsor, phase and state. Refreshed daily from the ClinicalTrials.gov registry.

15
Recruiting now
18
Studies tracked
New Jersey
Selected state
Recruiting Phase 1/Phase 2
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Small Cell Lung Cancer Extensive Stage
Merck Sharp & Dohme LLC · started 2026-01-29
📍 California · Colorado · Florida · Kentucky · Missouri · New Jersey · Oregon · South Dakota
NCT07227597 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF)
Novartis Pharmaceuticals · started 2026-06-16
📍 Connecticut · Georgia · New Jersey · Ohio
NCT07357727 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
Squamous Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC · started 2025-12-12
📍 Florida · Michigan · Missouri · New Jersey · New York · Ohio · Oregon · Tennessee
NCT07221474 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Neoplasm Malignant
Merck Sharp & Dohme LLC · started 2025-12-04
📍 Maryland · Michigan · Nevada · New Jersey · Utah · Virginia
NCT07209111 on ClinicalTrials.gov ↗
Active Phase 3
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
Tuberous Sclerosis Complex
Novartis Pharmaceuticals · started 2017-08-23
📍 Arizona · California · Colorado · Connecticut · Illinois · Minnesota · New Jersey · Ohio
NCT02962414 on ClinicalTrials.gov ↗
Recruiting Phase 2
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
Merck Sharp & Dohme LLC · started 2021-04-05
📍 Arkansas · California · Colorado · Kentucky · Minnesota · New Jersey · North Dakota · Texas
NCT04728893 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc. · started 2026-05-22
📍 Arizona · Florida · Georgia · Illinois · Maryland · New Jersey
NCT07621718 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Ovarian Cancer, Breast Cancer, Endometrial Cancer, Biliary Tract Cancer
NextCure, Inc. · started 2025-01-07
📍 California · Kentucky · Massachusetts · Missouri · New Jersey · New York · Ohio · Pennsylvania
NCT06774963 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Schizophrenia
Leal Therapeutics, Inc · started 2026-08
📍 Arkansas · California · Florida · Georgia · Maryland · New Jersey · Texas
NCT07734493 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
B-cell Malignancy, Relapsed Cancer, Refractory Cancer, B-cell Lymphoma
BeOne Medicines · started 2024-11-27
📍 Arizona · California · Florida · Kansas · Minnesota · Missouri · New Jersey · New York
NCT06634589 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes, Cytopenia
Takeda · started 2020-08-19
📍 Arkansas · California · Florida · Maryland · Michigan · New Jersey · New York · Pennsylvania
NCT04419649 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
SCLC
Zai Lab (Shanghai) Co., Ltd. · started 2024-01-23
📍 California · Connecticut · Florida · Michigan · New Jersey · New York · North Carolina · Ohio
NCT06179069 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Obesity, Overweight, Diabetes Mellitus, Type 2
Eli Lilly and Company · started 2025-10-16
📍 Arizona · Florida · Georgia · Nevada · New Jersey · Ohio · Texas · Utah
NCT07215559 on ClinicalTrials.gov ↗
Active Phase 2
A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression
Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive
AbbVie · started 2024-07-29
📍 California · Kentucky · Maryland · Missouri · Nevada · New Jersey · New York · North Carolina
NCT06365853 on ClinicalTrials.gov ↗
Recruiting Phase 1
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
T-cell NHL (PTCL or CTCL)
Kyowa Kirin, Inc. · started 2026-09
📍 California · Florida · Georgia · Iowa · Massachusetts · Missouri · New Jersey · New York
NCT07192471 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Ulcerative Colitis
AbbVie · started 2025-07-28
📍 Arizona · California · Florida · Georgia · Illinois · New Jersey · Ohio · Pennsylvania
NCT07071519 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Type 2 Diabetes
Eli Lilly and Company · started 2025-03-28
📍 Arizona · California · Florida · Georgia · Idaho · Indiana · New Jersey · New York
NCT06897475 on ClinicalTrials.gov ↗
Active Phase 1
A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
Colorectal Carcinoma, Gastric Carcinoma, Pancreatic Ductal Adenocarcinoma
Boehringer Ingelheim · started 2025-03-28
📍 California · Connecticut · Georgia · New Jersey
NCT06882746 on ClinicalTrials.gov ↗
No trials match your search.

Browse by state

California · 112 Florida · 111 Georgia · 60 Colorado · 54 Arizona · 53 Illinois · 48 New York · 44 Massachusetts · 41 Connecticut · 38 Alabama · 37 Michigan · 30 Indiana · 27 Maryland · 27 Ohio · 26 Arkansas · 23 Kentucky · 21

Browse by condition

Prostate Cancer · 5 Ovarian Cancer · 4 Overweight · 4 Obesity · 4 Systemic Lupus Erythematosus · 3 Ulcerative Colitis · 3 Follicular Lymphoma · 3 Heart Failure · 3 Non-small Cell Lung Cancer · 3 Lymphoma, Large B-Cell, Diffuse · 2 Diabetes Mellitus, Type 1 · 2 Breast Neoplasms · 2 B-cell Malignancy · 2 Hidradenitis Suppurativa · 2 Acute Myeloid Leukemia · 2 Ovarian Neoplasms · 2
Cite this page

Priya Life Science (2026). Clinical Trials in the USA Tracker. Available at: https://priyalifescience.com/clinical-trials-usa/state/new-jersey (Accessed: 22 August 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one US site, most recently updated first, refreshed daily. This is a curated slice of the full registry, not every US trial. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish and EU sites, see our Ireland and EU trackers.